NOT KNOWN DETAILS ABOUT HEMGENIX

Amount of qualified clients: CDEC reviewed the uncertainty in the volume of people with moderately significant to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some sufferers who're classified as getting mild or moderate illness may have a severe bleeding phenoty